DMAC: DiaMedica Therapeutics Inc
DMAC exchange rate has changed by -11.24% for today. During the day, the instrument was traded at a low of 7.49 and at a high of 8.62.
Follow DiaMedica Therapeutics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
DMAC News
- DiaMedica to conduct additional study for preeclampsia treatment
- Cisco, Flutter, Manulife and more set to report earnings Wednesday
- DiaMedica Therapeutics stock initiated with Buy rating at TD Cowen
- Tracking Leon Cooperman’s ~$3B Omega Advisors Portfolio – Q2 2025 Update
- DiaMedica Therapeutics, Inc. (DMAC) is a Great Momentum Stock: Should You Buy?
- After Golden Cross, DiaMedica Therapeutics, Inc. (DMAC)'s Technical Outlook is Bright
- Wall Street Analysts Believe DiaMedica Therapeutics (DMAC) Could Rally 100.81%: Here's is How to Trade
- What Makes DiaMedica Therapeutics, Inc. (DMAC) a Strong Momentum Stock: Buy Now?
- Does DiaMedica Therapeutics (DMAC) Have the Potential to Rally 114.06% as Wall Street Analysts Expect?
- DiaMedica: Interim Results Brings Study Expansions For DM199 In Preeclampsia (NASDAQ:DMAC)
- DiaMedica therapeutics (DMAC): Trill AB buys $5.4m in shares
- DiaMedica therapeutics (DMAC) shareholder TomEnterprise Private AB buys $10M in stock
- DiaMedica Therapeutics closes $30.1 million private placement
- DiaMedica secures $30.1 million in private placement for clinical trials
- DiaMedica shares drop 35% following InvestingPro’s overvalued warning
- DiaMedica stock price target raised to $12 from $10 at H.C. Wainwright
- DiaMedica reports positive interim results for preeclampsia treatment
- DiaMedica Therapeutics Announces Inclusion in the Russell 2000 ® and Russell 3000 ® Indexes
- H.C. Wainwright holds DiaMedica stock Buy rating, $10 target
- DiaMedica Therapeutics to Present at Jefferies Global Healthcare Conference 2025
- DiaMedica Therapeutics Announces Key Opinion Leader Webinar on DM199 (Rinvecalinase Alfa) for the Treatment of Preeclampsia
- DiaMedica Therapeutics reports annual meeting results
- Earnings call transcript: DiaMedica Therapeutics Q1 2025 earnings beat expectations
- DiaMedica Therapeutics: Stroke Developer With Low Cash Reserve (NASDAQ:DMAC)
Frequently Asked Questions
What is DMAC stock price today?
DiaMedica Therapeutics Inc stock is priced at 7.58 today. It trades within 7.49 - 8.62, yesterday's close was 8.54, and trading volume reached 1644. The live price chart of DMAC shows these updates.
Does DiaMedica Therapeutics Inc stock pay dividends?
DiaMedica Therapeutics Inc is currently valued at 7.58. Dividend policy depends on the company, while investors also watch 34.16% and USD. View the chart live to track DMAC movements.
How to buy DMAC stock?
You can buy DiaMedica Therapeutics Inc shares at the current price of 7.58. Orders are usually placed near 7.58 or 7.88, while 1644 and -11.35% show market activity. Follow DMAC updates on the live chart today.
How to invest into DMAC stock?
Investing in DiaMedica Therapeutics Inc involves considering the yearly range 3.19 - 10.42 and current price 7.58. Many compare -6.65% and 82.21% before placing orders at 7.58 or 7.88. Explore the DMAC price chart live with daily changes.
What are DiaMedica Therapeutics Inc stock highest prices?
The highest price of DiaMedica Therapeutics Inc in the past year was 10.42. Within 3.19 - 10.42, the stock fluctuated notably, and comparing with 8.54 helps spot resistance levels. Track DiaMedica Therapeutics Inc performance using the live chart.
What are DiaMedica Therapeutics Inc stock lowest prices?
The lowest price of DiaMedica Therapeutics Inc (DMAC) over the year was 3.19. Comparing it with the current 7.58 and 3.19 - 10.42 shows potential long-term entry points. Watch DMAC moves on the chart live for more details.
When did DMAC stock split?
DiaMedica Therapeutics Inc has gone through stock splits historically. These changes are visible in , 8.54, and 34.16% after corporate actions.
- Previous Close
- 8.54
- Open
- 8.55
- Bid
- 7.58
- Ask
- 7.88
- Low
- 7.49
- High
- 8.62
- Volume
- 1.644 K
- Daily Change
- -11.24%
- Month Change
- -6.65%
- 6 Months Change
- 82.21%
- Year Change
- 34.16%
- Act
- Fcst
- Prev